Verteporfin Therapy in Occult With No Classic CNV Due to AMD: Results of the Photodynamic Therapy in Occult-Only Lesions Study

Eye - United Kingdom
doi 10.1038/eye.2008.158
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Impact of Lesion Size on Photodynamic Therapy With Verteporfin of Predominantly Classic Lesions in Age Related Macular Degeneration

British Journal of Ophthalmology
Molecular NeuroscienceOphthalmologySensory SystemsCellular
2005English

Photodynamic Therapy With Verteporfin for Polypoidal Choroidal Vasculopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2008English

Bleeding From Occult Tumors During Anticoagulant Therapy

Circulation
Cardiovascular MedicinePhysiologyCardiology
1962English

Verteporfin Photodynamic Therapy for Neovascular Age-Related Macular Degeneration: Cohort Study for the UK.

Health Technology Assessment
MedicineHealth Policy
2012English

Contrast Enhanced-Magnetic Resonance Imaging as a Surrogate to Map Verteporfin Delivery in Photodynamic Therapy

Journal of Biomedical Optics
ElectronicOpticsMolecular Physics,OpticalBiomaterialsAtomicMagnetic MaterialsBiomedical Engineering
2013English

Photodynamic Therapy for Maculopathy Due to Radiation Retinopathy

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2004English

A Case of Presumed Choroidal Metastasis From Carcinoid Tumor Treated by Photodynamic Therapy With Verteporfin

Clinical Ophthalmology
Ophthalmology
2013English

The Introduction of Verteporfin Photodynamic Therapy in the UK: PDT Users Group (PDTUG) Surveillance Programme Report 1

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
2007English

Verteporfin-Based Photodynamic Therapy Overcomes Gemcitabine Insensitivity in a Panel of Pancreatic Cancer Cell Lines

Lasers in Surgery and Medicine
DermatologySurgery
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy